Mark A. Bryniarski

Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial

Rabi Yacoub, Melinda M. Nugent, Weijin Cai et al. · PLoS ONE · 2017 · 138 citations · Full text

Nutrition, Dysbiosis, Gut Microbiota +21

Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress

Chao Tong, Alex Morrison, Samantha Mattison et al. · The FASEB Journal · 2012 · 120 citations · Full text

Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis

Lee Chaves, Daniel McSkimming, Mark A. Bryniarski et al. · American Journal of Physiology-Renal Physiology · 2018 · 56 citations

Probiotic, Uremic Milieu, Systems Biology +13

In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model

Xiaowen Guan, Mark A. Bryniarski, Marilyn E. Morris · The AAPS Journal · 2018 · 48 citations

Tumor Biology, Drug Targeting, Endocrine-related Cancer +10

Increased megalin expression in early type 2 diabetes: role of insulin-signaling pathways

Mark A. Bryniarski, Benjamin M. Yee, Irum Jaffri et al. · American Journal of Physiology-Renal Physiology · 2018 · 31 citations · Full text